ERLOTINIB
ERLOTINIB is a medication used in the treatment of certain types of lung cancer. It belongs to the category of Uncategorised medicines and is manufactured by NATCO. Each pack contains 30 tablets.
Active Ingredients:
The active ingredient in ERLOTINIB is erlotinib hydrochloride.
Pharmacological Properties:
ERLOTINIB belongs to a class of medications known as tyrosine kinase inhibitors. It works by blocking the action of a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells.
Indications:
ERLOTINIB is indicated for the treatment of non-small cell lung cancer that has metastasized (spread to other parts of the body) and has certain mutations in the EGFR gene.
Contraindications:
ERLOTINIB should not be used in patients who are allergic to erlotinib or any of the other ingredients in the medication. It should also be avoided in pregnant women as it can harm the unborn baby.
Dosage:
The typical dose of ERLOTINIB is 150 mg taken once daily on an empty stomach, at least one hour before or two hours after eating.
Side Effects:
Common side effects of ERLOTINIB may include rash, diarrhea, nausea, vomiting, fatigue, and loss of appetite. Serious side effects such as difficulty breathing, chest pain, and liver problems may occur rarely.
Drug Interactions:
ERLOTINIB may interact with certain medications such as proton pump inhibitors (PPIs), rifampicin, and warfarin. It is important to inform your healthcare provider about all the medications you are taking before starting ERLOTINIB.
Patient Counseling:
Patients taking ERLOTINIB should be advised to report any new or worsening symptoms to their healthcare provider. It is important to follow the prescribed dosing schedule and to take the medication exactly as directed.
Clinical Evidence:
Clinical studies have demonstrated the effectiveness of ERLOTINIB in prolonging progression-free survival and improving overall survival in patients with EGFR mutation-positive non-small cell lung cancer.
Frequently Asked Questions:
1. What is the price of ERLOTINIB?
The actual MRP of ERLOTINIB is Rs. 11,279.62, but it is available at a discounted price of Rs. 9,425, representing a discount of 16.44%.
2. Can ERLOTINIB cure lung cancer?
ERLOTINIB is not a cure for lung cancer, but it can help in slowing down the progression of the disease and improving quality of life in patients with certain types of lung cancer.
3. How long should I take ERLOTINIB?
The duration of treatment with ERLOTINIB is determined by your healthcare provider based on individual response and tolerability. It is important to continue taking the medication as long as your doctor recommends.
4. Are there any special precautions to take while on ERLOTINIB?
Patients taking ERLOTINIB should avoid grapefruit and grapefruit juice as they may interact with the medication. It is also important to use effective contraception during treatment as ERLOTINIB can harm an unborn baby.
5. Can I take other supplements or vitamins with ERLOTINIB?
It is important to consult your healthcare provider before taking any other supplements or vitamins while on ERLOTINIB as they may interact with the medication and affect its efficacy.
This expanded content should help provide detailed information about ERLOTINIB for visitors to your website.
